With very little fanfare, the US Food and Drug Administrationís Center for Drug Evaluation and Research (CDER) internet web site has expanded its
capability to provide cancer-related information for consumers,
patients, and health care professionals.
This new web page, Oncology Tools at http://www.fda.gov/cder/cancer, can be searched
by specific types of cancer and by approved drug therapies. This
will make it easier for consumers and patients to obtain
information about different types of cancer and treatments, as
well as clinical trials and patient support groups available to them.
Internet users can now directly access such documents as
cancer drug labeling, approval summaries, and advisory committee
transcripts. Specialized information is also available for
health care professionals and others and includes cancer-related
regulatory tools, references for performing clinical studies, and
drug dose calculators.
The Oncology Tools page was developed by the Division of
Oncology Drug Products with the support of CDER's Office of
Training and Communications in order to make the web site more
user friendly to the wide range of different groups that use it.
FDA review divisions responsible for oncology products
include the Center for Drug Evaluation and Research (CDER), the
Center for Biologics Evaluation and Research (CBER), the Center
for Devices and Radiological Health (CDRH), the Center for Food
Safety and Nutrition (CFSAN) and FDA's Office of Special Health
Initiatives (OSHI). The new website includes a link to each of
the other centers. FDA's Office of Special Health Issues (OSHI)
works with cancer patients and cancer patient advocacy programs
on issues related to the FDA drug approval process, cancer
clinical trials and access to investigational therapies.
For further information about CDER's web site and this new
page, please send your comments and questions to the CDER
Webmaster at email@example.com or use the comments form provided on the web site.